Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00582010

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation

Sponsor: Mallinckrodt

Conditions Liver Injury Reperfusion Injury

Interventions inhaled nitric oxide nitrogen gas

Updated 6 times since 2017 Last updated: Nov 5, 2014 Started: Apr 30, 2008 Primary completion: Mar 31, 2009 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Liver Injury and Reperfusion Injury, this trial is completed. The trial is conducted by Mallinckrodt and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mallinckrodt
University of Alabama at Birmingham
University of Washington

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States
• Seattle, United States